1. Zoladek, Jim, Cannac, Marion, Seite, Maël, Wilson, Sam J, Nisole, Sébastien. 2025. MITD1 is a brain-specific interferon-inducible factor that inhibits flavivirus replication. In Proceedings of the National Academy of Sciences of the United States of America, 122, e2502064122. doi:10.1073/pnas.2502064122. https://pubmed.ncbi.nlm.nih.gov/40112111/
2. Zhang, Ye, Li, Yanze, Qiu, Qiangmin, Du, Yang, Liu, Xiuheng. 2022. MITD1 Deficiency Suppresses Clear Cell Renal Cell Carcinoma Growth and Migration by Inducing Ferroptosis through the TAZ/SLC7A11 Pathway. In Oxidative medicine and cellular longevity, 2022, 7560569. doi:10.1155/2022/7560569. https://pubmed.ncbi.nlm.nih.gov/36046690/
3. Lee, Seongju, Chang, Jaerak, Renvoisé, Benoît, Yang, Sarah, Blackstone, Craig. 2012. MITD1 is recruited to midbodies by ESCRT-III and participates in cytokinesis. In Molecular biology of the cell, 23, 4347-61. doi:10.1091/mbc.E12-04-0292. https://pubmed.ncbi.nlm.nih.gov/23015756/
4. Wang, Yapeng, Peng, Mou, Zhong, Yawen, Zhu, Liang, Jin, Xin. 2023. The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis. In Oncogene, 42, 952-966. doi:10.1038/s41388-023-02613-w. https://pubmed.ncbi.nlm.nih.gov/36732658/
5. Duan, Chun. 2022. LncRNA SLC16A1-AS1 contributes to the progression of hepatocellular carcinoma cells by modulating miR-411/MITD1 axis. In Journal of clinical laboratory analysis, 36, e24344. doi:10.1002/jcla.24344. https://pubmed.ncbi.nlm.nih.gov/35293026/
智鼠故事 
